Systematic review and meta-analysis of the bone protective effect of phytoestrogens on osteoporosis in ovariectomized rats

Nutrition Research

Volumn 34, Issue 6, 2014, Pages 467-477

  Fu, Song wen ^a   Zeng, Gao feng ^a   Zong, Shao hui ^b   Zhang, Zhi yong ^a   Zou, Bin ^a   Fang, Ye ^a   Lu, Li ^a   Xiao, De qiang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Bone histomorphometric parameters; Bone mineral density; Bone turnover markers; Meta analysis; Osteoporosis; Ovariecomized rat; Phytoestrogens

Indexed keywords

ACHYRANTHES BIDENTATA EXTRACT; ALKALINE PHOSPHATASE; APIGENIN; CISSUS QUADRANGULARIS EXTRACT; EUCOMMIA ULMOIDES EXTRACT; FERUTININ; GENISTEIN; GINKGO BILOBA EXTRACT; ICARIIN; ISOFLAVONE; ONOBRYCHIS EBENOIDES EXTRACT; OSTEOCALCIN; PHYTOESTROGEN; PLANT EXTRACT; PRUNELLA VULGARIS EXTRACT; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; BLUEBERRY; BONE DENSITY; BONE MASS; FEMUR; MEDICINAL PLANT; NONHUMAN; ONOBRYCHIS EBENOIDES; OPUNTIA HUMIFUSA; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; RAT; REVIEW; SOYBEAN; SYSTEMATIC REVIEW; TRABECULAR BONE; ANIMAL; BLOOD; BONE; BONE DEVELOPMENT; DRUG EFFECTS; FACTUAL DATABASE; FEMALE; META ANALYSIS; OSTEOLYSIS; PREVENTION AND CONTROL;

ANIMALIA; RATTUS;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; DATABASES, FACTUAL; FEMALE; OSTEOCALCIN; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PHYTOESTROGENS; RATS;

EID: 84904104282     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.05.003     Document Type: Review

References (72)

1. Looker A.C., Melton L.J., Harris T.B., Borrud L.G., Shepherd J.A. Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res 2010, 25:64-71.
2. Zhang Z.Q., Ho S.C., Chen Z.Q., Zhang C.X., Chen Y.M. Reference values of bone mineral density and prevalence of osteoporosis in Chinese adults. Osteoporos Int 2013, 67:321-331.
3. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996, 11:1043-1051.
4. Brewer L., Williams D., Moore A. Current and future treatment options in osteoporosis. Eur J Clin Pharmacol 2011, 67:321-331.
5. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology 1998, 139:2659-2661.
6. Li C.I., Malone K.E., Porter P.L., Weiss N.S., Tang M.T., Cushing-Haugen K.L., et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003, 289:3254-3263.
7. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
8. Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens) 2007, 6:173-193.
9. Cos P., De Bruyne T., Apers S., Vanden Berghe D., Pieters L., Vlietinck A.J. Phytoestrogens: recent developments. Planta Med 2003, 69:589-599.
10. Wang H., Murphy P.A. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994, 42:1666-1673.
11. Thompson L.U., Robb P., Serraino M., Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991, 16:43-52.
12. Chiang S.S., Chang S.P., Pan T.M. Osteoprotective effect of Monascus-fermented Dioscorea in ovariectomized rat model of postmenopausal osteoporosis. J Agric Food Chem 2011, 59:9150-9157.
13. Thompson L.U., Boucher B.A., Liu Z., Cotterchio M., Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 2006, 54:184-201.
14. Mei J., Yeung S.S., Kung A.W. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001, 86:5217-5221.
15. Somekawa Y., Chiguchi M., Ishibashi T., Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001, 97:109-115.
16. Zhang X., Shu X.O., Li H., Yang G., Li Q., Gao Y.T., et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005, 165:1890-1895.
17. Branca F. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 2003, 62:877-887.
18. Usui T. Pharmaceutical prospects of phytoestrogens. Endocr J 2006, 53:7-20.
19. Yang T.S., Wang S.Y., Yang Y.C., Su C.H., Lee F.K., Chen S.C., et al. Effects of standardized phytoestrogen on Taiwanese menopausal women. Taiwan J Obstet Gynecol 2012, 51:229-235.
20. Anderson L.N., Cotterchio M., Boucher B.A., Kreiger N. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Int J Cancer 2013, 132:1683-1692.
21. Macleod M.R., O'Collins T., Horky L.L., Howells D.W., Donnan G.A. Systematic review and meta-analysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 2005, 25:713-721.
22. Pound P., Ebrahim S., Sandercock P., Bracken M.B., Roberts I. Where is the evidence that animal research benefits humans?. BMJ 2004, 328:514-517.
23. Macleod M.R., O'Collins T., Howells D.W., Donnan G.A. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004, 35:1203-1208.
24. Roberts C., Pound P. The need for systematic reviews of animal studies. Chin J Evid Based Med 2005, 5:3-4.
25. Taku K., Melby M.K., Kurzer M.S., Mizuno S., Watanabe S., Ishimi Y. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: systematic review and meta-analysis of randomized controlled trials. Bone 2010, 47:413-423.
26. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011, [p. Available from www.cochrane-handbook.org]. J.P.T. Higgins, S. Green (Eds.).
27. Kilkenny C., Browne W., Cuthill I.C., Emerson M., Altman D.G. Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 2010, 160:1577-1579.
28. Jove M., Pamplona R., Prat J., Arola L., Portero-Otin M. Atherosclerosis prevention by nutritional factors: a meta-analysis in small animal models. Nutr Metab Cardiovasc Dis 2013, 23:84-93.
29. Wen J., Li Y.P. The selection of a summary statistic for use in meta-analysis. Chin J Evid Based Med 2007, 7:606-613.
30. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
31. Aswar U.M., Mohan V., Bodhankar S.L. Antiosteoporotic activity of phytoestrogen-rich fraction separated from ethanol extract of aerial parts of Cissus quadrangularis in ovariectomized rats. Indian J Pharmacol 2012, 44:345-350.
32. Breitman P.L., Fonseca D., Cheung A.M., Ward W.E. Isoflavones with supplemental calcium provide greater protection against the loss of bone mass and strength after ovariectomy compared to isoflavones alone. Bone 2003, 33:597-5.
33. Cavani F., Ferretti M., Carnevale G., Bertoni L., Zavatti M., Palumbo C. Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats. J Bone Miner Metab 2012, 30:619-629.
34. Chang K.L., Hu Y.C., Hsieh B.S., Cheng H.L., Hsu H.W., Huang L.W., et al. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats. Nutrition 2013, 29:250-257.
35. Dai R., Ma Y., Sheng Z., Jin Y., Zhang Y., Fang L., et al. Effects of genistein on vertebral trabecular bone microstructure, bone mineral density, microcracks, osteocyte density, and bone strength in ovariectomized rats. J Bone Miner Metab 2008, 26:342-349.
36. Devareddy L., Hooshmand S., Collins J.K., Lucas E.A., Chai S.C., Arjmandi B.H. Blueberry prevents bone loss in ovariectomized rat model of postmenopausal osteoporosis. J Nutr Biochem 2008, 19:694-699.
37. Dontas I., Halabalaki M., Moutsatsou P., Mitakou S., Papoutsi Z., Khaldi L., et al. Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats. Maturitas 2006, 53:234-242.
38. Ferretti M., Bertoni L., Cavani F., Zavatti M., Resca E., Carnevale G., et al. Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. J Anat 2010, 217:48-56.
39. Hong G.E., Pyun C.W., Kim S.K., Han K.H., Yang C.Y., Lee C.H. Effects of fermented black soybean pulp on lipid and bone metabolism in ovariectomized rats. Food Sci Biotechnol 2012, 21:1397-03.
40. Hooshmand S., Juma S., Arjmandi B.H. Combination of genistin and fructooligosaccharides prevents bone loss in ovarian hormone deficiency. J Med Food 2010, 13:320-325.
41. Lee M.Y., Chang K.H. Effects of cheonggukjang containing arrowroot isoflavones on bone metabolism in ovariectomized rats. Food Sci Biotechnol 2011, 20:335-341.
42. Nian H., Ma M.H., Nian S.S., Xu L.L. Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 2009, 16:320-326.
43. Park J., Hahm S.W., Son Y.S. Effects of Cheonnyuncho (Opuntia humifusa) seeds treatment on the mass, quality, and the turnover of bone in ovariectomized rats. Food Sci Biotechnol 2011, 20:1517-1524.
44. Park J.A., Ha S.K., Kang T.H., Oh M.S., Cho M.H., Lee S.Y., et al. Protective effect of apigenin on ovariectomy-induced bone loss in rats. Life Sci 2008, 82:1217-1223.
45. Shirke S.S., Jadhav S.R., Jagtap A.G. Osteoprotective effect of Phaseolus vulgaris L in ovariectomy-induced osteopenia in rats. Menopause 2009, 16:589-596.
46. Trivedi R., Kumar A., Gupta V., Kumar S., Nagar G.K., Romero J.R., et al. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol. Mol Cell Endocrinol 2009, 302:86-91.
47. Zhang R., Hu S.J., Li C., Zhang F., Gan H.Q., Mei Q.B. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. J Ethnopharmacol 2012, 139:12-18.
48. Zhang R., Liu Z.G., Li C., Hu S.J., Liu L., Wang J.P., et al. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 2009, 45:553-559.
49. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991, 15:175-191.
50. Sliwinski L., Folwarczna J., Janiec W., Grynkiewicz G., Kuzyk K. Differential effects of genistein, estradiol and raloxifene on rat osteoclasts in vitro. Pharmacol Rep 2005, 57:352-359.
51. Poulsen R.C., Kruger M.C. Soy phytoestrogens: impact on postmenopausal bone loss and mechanisms of action. Nutr Rev 2008, 66:359-374.
52. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332:305-311.
53. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
54. Stein G.S., Lian J.B., van Wijnen A.J., Stein J.L., Montecino M., Javed A., et al. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene 2004, 23:4315-4329.
55. Xiong W., Wei Q., Liu X.M. Introduction to systematic reviews of animal studies. Chin J Evid Based Med 2005, 5:161-163.
56. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
57. Bebarta V., Luyten D., Heard K. Emergency medicine animal research: does use of randomization and blinding affect the results?. Acad Emerg Med 2003, 10:684-687.
58. Bedell S., Nachtigall M., Naftolin F. The pros and cons of plant estrogens for menopause. J Steroid Biochem Mol Biol 2014, 139:225-236.
59. Adjakly M., Ngollo M., Boiteux J.P., Bignon Y.J., Guy L., Bernard-Gallon D. Genistein and daidzein: different molecular effects on prostate cancer. Anticancer Res 2013, 33:39-44.
60. Lof M., Weiderpass E. Epidemiologic evidence suggests that dietary phytoestrogen intake is associated with reduced risk of breast, endometrial, and prostate cancers. Nutr Res 2006, 26:609-619.
61. Lee AH, Su D, Pasalich M, Tang L, Binns CW, Qiu L. Soy and isoflavone intake associated with reduced risk of ovarian cancer in southern Chinese women. Nutr Res 34, 2014, 304-307.
62. Douglas C.C., Johnson S.A., Arjmandi B.H. Soy and its isoflavones: the truth behind the science in breast cancer. Anticancer Agents Med Chem 2013, 13:1178-1187.
63. Hassan H.A., Abdel-Wahhab M.A. Effect of soybean oil on atherogenic metabolic risks associated with estrogen deficiency in ovariectomized rats: dietary soybean oil modulate atherogenic risks in overiectomized rats. J Physiol Biochem 2012, 68:247-253.
64. Kayisli U.A., Guzeloglu-Kayisli O., Guzel E., Arici A. Genistein inhibits cell proliferation and stimulates apoptosis in human coronary artery endothelial cells. Gynecol Obstet Invest 2013, 75:235-242.
65. Reinwald S., Weaver C.M. Soy isoflavones and bone health: a double-edged sword?. J Nat Prod 2006, 69:450-459.
66. Johnson E.B., Muto M.G., Yanushpolsky E.H., Mutter G.L. Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol 2001, 98:10-15.
67. Mlynarczuk J., Wrobel M.H., Kotwica J. Adverse influence of coumestrol on secretory function of bovine luteal cells in the first trimester of pregnancy. Environ Toxicol 2013, 28:411-418.
68. Sato F., Martinez N.E., Shahid M., Rose J.W., Carlson N.G., Tsunoda I. Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol 2013, 183:1390-1396.
69. Jefferson W.N., Patisaul H.B., Williams C.J. Reproductive consequences of developmental phytoestrogen exposure. Reproduction 2012, 143:247-260.
70. Lagari V.S., Levis S. Phytoestrogens in the prevention of postmenopausal bone loss. J Clin Densitom 2013, 16:445-449.
71. Lagari V.S., Levis S. Phytoestrogens for menopausal bone loss and climacteric symptoms. J Steroid Biochem Mol Biol 2014, 139:294-301.
72. Salari Sharif P., Nikfar S., Abdollahi M. Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis. Age (Dordr) 2011, 33:421-431.